HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

CTLA-4 blockade differentially influences the outcome of non-lethal and lethal Plasmodium yoelii infections.

Abstract
An immune response against malaria has to be tightly controlled. The production of pro-inflammatory cytokines is required to control parasites but the same cytokines are also involved in severe malaria. We have shown that CTLA-4 expression during Plasmodium berghei malaria dampens the immune response. This strain provokes a pro-inflammatory immune response that is associated with the pathology of cerebral malaria. Accordingly a blockade of CTLA-4 during the blood-stage of P. berghei malaria leads to an exacerbation of disease. To analyze the effects of a CTLA-4 blockade in a malaria model which is not prone to immune pathology we employed P. yoelii infection. Blood-stage infection led to a rapid induction of CTLA-4 on T cells. Using the non-lethal P. yoelii strain Py17NL we found that a blockade of CTLA-4 resulted in an increased T cell activation and IFN-gamma production, which was accompanied by a lower peak parasitemia and earlier parasite clearance. In contrast, blockade of CTLA-4 during infection with a P. yoelii strain exhibiting a higher parasitemia induced markedly increased serum-levels of TNF-alpha, which was associated with severe inflammation and reduced survival.
AuthorsBernd Lepenies, Iris Gaworski, Susanne Tartz, Jean Langhorne, Bernhard Fleischer, Thomas Jacobs
JournalMicrobes and infection (Microbes Infect) Vol. 9 Issue 6 Pg. 687-94 (May 2007) ISSN: 1286-4579 [Print] France
PMID17398134 (Publication Type: Comparative Study, Journal Article, Research Support, Non-U.S. Gov't)
Chemical References
  • Antibodies, Blocking
  • Antibodies, Monoclonal
  • Antigens, CD
  • Antigens, Differentiation
  • CTLA-4 Antigen
  • Ctla4 protein, mouse
  • Tumor Necrosis Factor-alpha
  • Interferon-gamma
Topics
  • Animals
  • Antibodies, Blocking (immunology, pharmacology)
  • Antibodies, Monoclonal (immunology, pharmacology)
  • Antigens, CD (drug effects, immunology)
  • Antigens, Differentiation (drug effects, immunology)
  • CTLA-4 Antigen
  • Inflammation (pathology)
  • Interferon-gamma (blood)
  • Lymphocyte Activation
  • Malaria (immunology, pathology, virology)
  • Mice
  • Mice, Inbred BALB C
  • Parasitemia
  • Plasmodium yoelii (pathogenicity)
  • T-Lymphocytes (immunology)
  • Tumor Necrosis Factor-alpha (blood)
  • Virulence

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: